Nikko Asset Management Americas’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.89M | Sell |
1,589,117
-1,336,906
| -46% | -$3.28M | 0.04% | 110 |
|
|
2025
Q1 | $5.82M | Sell |
2,926,023
-164,157
| -5% | -$327K | 0.08% | 95 |
|
|
2024
Q4 | $9.02M | Sell |
3,090,180
-92,275
| -3% | -$269K | 0.1% | 87 |
|
|
2024
Q3 | $12.3M | Sell |
3,182,455
-55,930
| -2% | -$216K | 0.14% | 83 |
|
|
2024
Q2 | $16.5M | Sell |
3,238,385
-126,278
| -4% | -$645K | 0.19% | 72 |
|
|
2024
Q1 | $23.5M | Sell |
3,364,663
-154,366
| -4% | -$1.08M | 0.23% | 65 |
|
|
2023
Q4 | $31.2M | Sell |
3,519,029
-115,819
| -3% | -$1.03M | 0.3% | 58 |
|
|
2023
Q3 | $34.6M | Buy |
3,634,848
+570,232
| +19% | +$5.42M | 0.41% | 52 |
|
|
2023
Q2 | $44.8M | Buy |
3,064,616
+2,065,283
| +207% | +$30.2M | 0.47% | 44 |
|
|
2023
Q1 | $11M | Buy |
999,333
+511,107
| +105% | +$5.62M | 0.13% | 78 |
|
|
2022
Q4 | $9.04M | Buy |
+488,226
| New | +$9.04M | 0.13% | 88 |
|